Inventor · disambiguated record
Claudio Andres Hetz Flores
Also filed as: HETZ FLORES CLAUDIO · HETZ FLORES CLAUDIO ANDRES · HETZ FLORES CLAUDIO ANDRÉS
4 granted patents·3 pending applications·2 citations·filing 2015–2020
60Inventor score
Files withUNIV CHILE7
Top patents by PatentIndex Score
7 records- 0173US10889831B2AAV/UPR-plus virus, UPR-plus fusion protein, genetic treatment method and its use in treatment of neurodegenerative diseases, such as Parkinson's disease and Huntington's disease, among othersUNIV CHILE·Filed 2016·Granted Jan 12, 2021·2 cites·18 claims
- 0260US11795476B2AAV/UPR-plus virus, UPR-plus fusion protein, genetic treatment method and its use in the treatment of neurodegenerative diseases, such as Parkinson's disease and Huntington's disease, among othersUNIV CHILE·Filed 2020·Granted Oct 24, 2023·0 cites·12 claims
- 0347US2021060178A1Aav/xbp1s-ha virus, gene therapy method and use thereof in the optimisation and improvement of learning, memory and cognitive capacitiesUNIV CHILE·Filed 2020·Application pending·0 cites
- 0443US11400166B2AAV/XBP1s-HA virus, gene therapy method and use thereof in the optimisation and improvement of learning, memory and cognitive capacitiesUNIV CHILE·Filed 2015·Granted Aug 2, 2022·0 cites·14 claims
- 0542US10512698B2Method for genetic treatment using the AAV-XBP1s/GFP virus and use thereof in the prevention and treatment of amyotrophic lateral sclerosisUNIV CHILE·Filed 2016·Granted Dec 24, 2019·0 cites·15 claims
- 0641US2022184175A1Treatment of aging or age-related disorders using xbp1UNIV CHILE·Filed 2020·Application pending·0 cites
- 0738US2020030391A1Virus aav/igf2, genetic treatment method and use thereof in protein misfolding-related diseases, such as huntington's diseaseUNIV CHILE·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Claudio Andres Hetz Flores files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →